Cytokinetics, Inc. (CYTK) Posts Q1 Loss of 27c/Share
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $82.19 +1.72%
Revenue Growth %: -75.4%
Financial Fact:
Income tax benefit: 0
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: -75.4%
Financial Fact:
Income tax benefit: 0
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Cytokinetics, Inc. (NASDAQ: CYTK) reported Q1 EPS of ($0.27), $0.07 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $8 million versus the consensus estimate of $7.69 million.
For earnings history and earnings-related data on Cytokinetics, Inc. (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Benchmark Reiterates Buy Rating on Kura Sushi USA Inc. (KRUS) Ahead of Q3 Print
- Argus starts SpaceX at Hold, sees record IPO as a multi-year re-rating challenge
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
